Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Neurizon Therapeutics Ltd
F:ECQ0
Neurizon Therapeutics Ltd
F:ECQ0
Price:
0.0475
EUR
4.4%
Market Closed
Market Cap:
€25.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Neurizon Therapeutics Ltd
F:ECQ0
|
AU |
|
Taskus Inc
NASDAQ:TASK
|
US |
|
Innovative Solutions and Support Inc
NASDAQ:IA
|
US |
|
D
|
Dexcom Inc
F:DC4
|
US |
|
P
|
Pultegroup Inc
XMUN:PU7
|
US |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
Wall St Price Targets
ECQ0 Price Forecast
Based on 3 analysts
Based on 3 analysts
+258% Upside
from
€0.0475
today
Neurizon Therapeutics Ltd (ECQ0)’s 12-month stock price forecast through October 2027 has a consensus target of €0.17, implying 258% upside. The forecast is based on price targets from 3 Wall Street analysts.
ECQ0 Analyst Rating
No ratings yet
No ratings yet
Neurizon Therapeutics Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ECQ0's stock price target?
Price Target
0.17
EUR
0.17
EUR
According to Wall Street analysts, the average 1-year price target for ECQ0 is 0.17 EUR with a low forecast of 0.1684 EUR and a high forecast of 0.175 EUR.